Aprazer now has ambitious plans to specialize in Oncological Tablet/Capsules dosage forms , as the next giant step. Towards the initial step, Aprazer has Tied up with BDR International for products Abiraterone & Sorafenib .
BDR has state – of – the – art manufacturing unit, specialized in Oncology oral formulations, is already commissioned and is into production. This unit located in Vadodara, Gujarat State is both WHO GMP and EU-GMP compliant. BDR has a new unit under manufacturing site in Halol District in Gujarat has been acquired and construction work is all set to commence. Once ready and operational, this facility will target for approval from various international accreditation agencies, including from US, Europe, African and Asian Health Authorities.